XEVUDY 500 MG CONCENTRADO PARA SOLUCION PARA PERFUSION

Glaxosmithkline Trading Services Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: b433838ebf7ac732
Drug Cima Aemps Name: XEVUDY 500 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1211562001
Holder Company Name: Glaxosmithkline Trading Services Limited
Marketing Company Name: Glaxosmithkline S.A.
Holder Company Detail Path: /organization/glaxosmithkline-trading-services-limited
Marketing Company Detail Path: /organization/glaxosmithkline-sa
Authorization Date: 2021-12-23
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 500 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Glaxosmithkline Trading Services Limited
Company Detail Path: /organization/glaxosmithkline-trading-services-limited

SOTROVIMAB

62,5 mg/ml

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 23, 2021

Approval ID

b433838ebf7ac732

Type

Standard